RenovoRx, Inc. (RNXT) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

Core Perspective - The company is focused on innovating cancer treatment by prioritizing patient well-being alongside tumor destruction, aiming to localize therapy for better outcomes [2]. Company Background and Progress - The company is making significant strides in both commercial and clinical aspects, laying a strong foundation for growth in 2026 [1][2]. - A two-pronged approach to market potential has been initiated, with the commercialization of their therapeutic solutions underway [3].